NEOPLASM
Clinical trials for NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new NEOPLASM trials appear
Sign up with your email to follow new studies for NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with stubborn cancers? SGT-53 trial begins
Disease control TerminatedThis early-stage study tests a drug called SGT-53 in children and young adults (ages 1-21) with solid tumors that have come back or not responded to treatment. The goal is to find the safest dose and understand side effects when given alone or with standard chemotherapy. The stud…
Matched conditions: NEOPLASM
Phase: PHASE1 • Sponsor: SynerGene Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 05:05 UTC
-
Why do drugs hurt some people? NIH launches blood study to find out
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood samples from people who have unexpected or severe side effects from drugs they are taking for cancer. The goal is to measure drug levels in the blood to understand why side effects happen in some people but not others. Participants must be at least 2 yea…
Matched conditions: NEOPLASM
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC